MEDI 255-First time disclosure of a novel series of CCR1 antagonists: From library hit to optimized lead

被引:0
|
作者
Merritt, J. Robert [1 ]
机构
[1] Pharmacopeia Inc, Med Chem, Cranbury, NJ 08512 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
255-MEDI
引用
收藏
页数:1
相关论文
共 9 条
  • [1] Identification of novel series of human CCR1 antagonists
    Xie, Yun Feng
    Sircar, Ila
    Lake, Kirk
    Komandla, Mallareddy
    Ligsay, Kathleen
    Li, Jian
    Xu, Kui
    Parise, Jason
    Schneider, Lisa
    Huang, Dingqiu
    Liu, Juping
    Sakurai, Naoki
    Barbosa, Miguel
    Jack, Rick
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 2215 - 2221
  • [2] MEDI 207-Discovery of novel, orally available piperidine-containing CCR1 antagonists
    Lu, Shou-Fu
    Chou, Yuo-Ling
    Lee, Wheeseong
    Liang, Xiaolin
    Phillips, Gary B.
    Schlyer, Sabine
    Wei, Robert G.
    Xu, Jinlou
    Yu, Hongyi
    Ge, Xue Snow
    Harirchian, Paymann
    Ribeiro, Sofia
    Subramanyam, Babu
    Walters, Janette
    Horuk, Richard
    Kochanny, Monica J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [3] MEDI 165-Discovery and optimization of a series of CCR4 antagonists from Hit to CD
    Mete, Antonio
    Andrews, Glen
    Baxter, Andrew
    Cheshire, David
    Ewart, Lorna
    Harper, Steve
    Hickling, Kevin
    Kindon, Nicholas
    McGinnity, Dermot
    Murray, Claire
    Stocks, Michael
    Tomkinson, Nicholas
    Wregget, Keith
    Young, Simon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [4] Novel, acidic CCR2 receptor antagonists: From hit to lead
    Zou, D.
    Zhai, H. A.
    Eckman, J.
    Higgins, P.
    Gillard, M.
    Knerr, L.
    Carre, S.
    Pasau, P.
    Collart, P.
    Grassi, J.
    Libertine, L.
    Nicolas, J. -M.
    Schwartz, C. E.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (03) : 185 - 191
  • [5] Discovery and Lead Optimization of a Novel Series of CC Chemokine Receptor 1 (CCR1)-Selective Piperidine Antagonists via Parallel Synthesis
    Cavallaro, Cullen L.
    Briceno, Stephanie
    Chen, Jing
    Cvijic, Mary Ellen
    Davies, Paul
    Hynes, John, Jr.
    Liu, Rui-Qin
    Mandlekar, Sandhya
    Rose, Anne V.
    Tebben, Andrew J.
    Van Kirk, Katy
    Watson, Andrew
    Wu, Hong
    Yang, Guchen
    Carter, Percy H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9643 - 9653
  • [6] From HTS hit to CD: Optimization of a novel series of CCR4 antagonists
    Mete, Antonio
    Andrews, Glen
    Baxter, Andrew
    Cheshire, David
    Ewart, Lorna
    Harper, Steve
    Hickling, Kevin
    Kindon, Nicholas
    McGinnity, Dermot
    Murray, Claire
    Stocks, Michael
    Tomkinson, Nicholas
    Wregget, Keith
    Young, Simon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [7] The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere template
    Kath, JC
    DiRico, AP
    Gladue, RP
    Martin, WH
    McElroy, EB
    Stock, IA
    Tylaska, LA
    Zheng, DY
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2163 - 2167
  • [8] Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead
    Terakado, Masahiko
    Suzuki, Hidehiro
    Hashimura, Kazuya
    Tanaka, Motoyuki
    Ueda, Hideyuki
    Kohno, Hiroshi
    Fujimoto, Taku
    Saga, Hiroshi
    Nakade, Shinji
    Habashita, Hiromu
    Takaoka, Yoshikazu
    Seko, Takuya
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 913 - 918
  • [9] Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation
    Procopiou, Panayiotis A.
    Ford, Alison J.
    Graves, Rebecca H.
    Hall, David A.
    Hodgson, Simon T.
    Lacroix, Yannick M. L.
    Needham, Deborah
    Slack, Robert J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (08) : 2730 - 2733